Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895864087> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2895864087 endingPage "153" @default.
- W2895864087 startingPage "150" @default.
- W2895864087 abstract "Prostate cancer is one of the most common malignancy of males found worldwide including in Asia, and is the second most commoncause of male death in Western countries. Specific cause of prostate cancer is not yet elucidated, but there are several risk factors as well.The diagnosis of prostate cancer is confirmed by digital rectal examination (DRE), prostate-specific antigen (PSA), and a biopsy withtrans-rectal ultrasonography (TRUS). However, the sensitivity of DRE and PSA examinations are low and not good enough to detectprostate cancer. Currently there is a new test called Engrailed-2 (EN2) examination with enzyme-linked immunosorbent assay (ELISA)micro method. The test is simple and uninvasive one. This study is aimed to know the validity of urinary EN2 protein level measurementto detect prostate cancer by analysing. This study was conducted at Dr. Hasan Sadikin Hospital Bandung between November 2012 untilMarch 2013. This study was a diagnostic test with cross sectional design. The subjects of study were men whom suspected to have prostatecancer by DRE, PSA value (≥4 ng/mL) and TRUS biopsy. Urinary EN2 protein levels were measured using ELISA micro method. Statisticalanalysis used Mann-Whitney test, table 2í—2 and ROC curve. In this study there are 50 subjects, where the result of positive biopsy forprostate cancer were found on 17 subjects and the negative were on 33 subjects. The study results on cut off value of >0.7 ng/mL gavethe sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 94.12%, 63.64%, 57.1%, 95.5% and 74%,respectively. In conclusion of this study, that the urinary EN2 protein level examination using ELISA micro method has the high sensitivityand moderate specificity, thus these procedure primarily can be used for the screening of prostate cancer." @default.
- W2895864087 created "2018-10-26" @default.
- W2895864087 creator A5004552539 @default.
- W2895864087 creator A5066682021 @default.
- W2895864087 creator A5066763131 @default.
- W2895864087 creator A5083522480 @default.
- W2895864087 date "2018-03-22" @default.
- W2895864087 modified "2023-10-18" @default.
- W2895864087 title "KEABSAHAN ENGRAILED-2 DI KANKER PROSTAT" @default.
- W2895864087 doi "https://doi.org/10.24293/ijcpml.v20i2.1084" @default.
- W2895864087 hasPublicationYear "2018" @default.
- W2895864087 type Work @default.
- W2895864087 sameAs 2895864087 @default.
- W2895864087 citedByCount "0" @default.
- W2895864087 crossrefType "journal-article" @default.
- W2895864087 hasAuthorship W2895864087A5004552539 @default.
- W2895864087 hasAuthorship W2895864087A5066682021 @default.
- W2895864087 hasAuthorship W2895864087A5066763131 @default.
- W2895864087 hasAuthorship W2895864087A5083522480 @default.
- W2895864087 hasBestOaLocation W28958640871 @default.
- W2895864087 hasConcept C121608353 @default.
- W2895864087 hasConcept C126322002 @default.
- W2895864087 hasConcept C126894567 @default.
- W2895864087 hasConcept C143998085 @default.
- W2895864087 hasConcept C2775934546 @default.
- W2895864087 hasConcept C2779399171 @default.
- W2895864087 hasConcept C2780101318 @default.
- W2895864087 hasConcept C2780192828 @default.
- W2895864087 hasConcept C2781217009 @default.
- W2895864087 hasConcept C2781406297 @default.
- W2895864087 hasConcept C29456083 @default.
- W2895864087 hasConcept C71924100 @default.
- W2895864087 hasConceptScore W2895864087C121608353 @default.
- W2895864087 hasConceptScore W2895864087C126322002 @default.
- W2895864087 hasConceptScore W2895864087C126894567 @default.
- W2895864087 hasConceptScore W2895864087C143998085 @default.
- W2895864087 hasConceptScore W2895864087C2775934546 @default.
- W2895864087 hasConceptScore W2895864087C2779399171 @default.
- W2895864087 hasConceptScore W2895864087C2780101318 @default.
- W2895864087 hasConceptScore W2895864087C2780192828 @default.
- W2895864087 hasConceptScore W2895864087C2781217009 @default.
- W2895864087 hasConceptScore W2895864087C2781406297 @default.
- W2895864087 hasConceptScore W2895864087C29456083 @default.
- W2895864087 hasConceptScore W2895864087C71924100 @default.
- W2895864087 hasIssue "2" @default.
- W2895864087 hasLocation W28958640871 @default.
- W2895864087 hasOpenAccess W2895864087 @default.
- W2895864087 hasPrimaryLocation W28958640871 @default.
- W2895864087 hasRelatedWork W1967456449 @default.
- W2895864087 hasRelatedWork W1997875975 @default.
- W2895864087 hasRelatedWork W2064191137 @default.
- W2895864087 hasRelatedWork W2090845149 @default.
- W2895864087 hasRelatedWork W2099948048 @default.
- W2895864087 hasRelatedWork W2102167265 @default.
- W2895864087 hasRelatedWork W2143331076 @default.
- W2895864087 hasRelatedWork W2148670124 @default.
- W2895864087 hasRelatedWork W2390982334 @default.
- W2895864087 hasRelatedWork W2417874801 @default.
- W2895864087 hasVolume "20" @default.
- W2895864087 isParatext "false" @default.
- W2895864087 isRetracted "false" @default.
- W2895864087 magId "2895864087" @default.
- W2895864087 workType "article" @default.